View Older Stories View More Recent Stories

Jun 4, 2018 09:07AM CytomX (CTMX) Presents Prelim. Clinical Proof-of-Concept Data from Probody Platform and CX-072 at ASCO
Jun 4, 2018 09:00AM CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probody™ Platform and CX-072 at 2018 ASCO Annual Meeting
Jun 1, 2018 07:30AM CytomX Announces Conference Call and Webcast to Review PROCLAIM-072 Clinical Data Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 31, 2018 07:30AM CytomX to Present at the Jefferies 2018 Healthcare Conference
May 22, 2018 07:32AM CytomX Therapeutics (CTMX) Announces FDA Clearance of IND Application for CX-2029
May 22, 2018 07:30AM CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-2029, a CD71-Directed Probody Therapeutic
May 17, 2018 06:52AM CytomX Therapeutics (CTMX) Announces Presentations at ASCO (Yesterday)
May 16, 2018 05:05PM CytomX Therapeutics Announces Presentations at 2018 ASCO Annual Meeting
May 9, 2018 04:05PM CytomX Therapeutics Announces First Quarter 2018 Financial Results
May 7, 2018 04:00PM CytomX to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
May 1, 2018 04:01PM CytomX Therapeutics to Announce First Quarter 2018 Financial Results
Mar 7, 2018 04:30PM CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational Update
Mar 1, 2018 04:05PM CytomX to Present at Upcoming Investor Conferences
Feb 22, 2018 04:05PM CytomX Therapeutics to Announce Full-Year 2017 Financial Results and Host Operational Update Webcast Conference Call
Dec 18, 2017 08:00AM CytomX Therapeutics Added to NASDAQ Biotechnology Index
Nov 28, 2017 08:34AM CytomX Therapeutics (CTMX) Announces FDA Acceptance of IND for CTLA-4 Probody Therapeutic
Nov 28, 2017 08:30AM CytomX Therapeutics Announces FDA Acceptance of Investigational New Drug Application for CTLA-4 Probody Therapeutic
Nov 7, 2017 04:57PM CytomX Announces Third Quarter 2017 Financial Results and Operational Progress
Nov 1, 2017 04:05PM CytomX to Present at the Jefferies 2017 London Healthcare Conference
Oct 26, 2017 04:26PM CytomX Therapeutics to Announce Third Quarter 2017 Financial Results
Oct 24, 2017 04:05PM CytomX Therapeutics Appoints Charles S. Fuchs, M.D., MPH to Board of Directors
Oct 16, 2017 01:00PM CytomX Announces Upcoming Poster Presentations at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference
Oct 3, 2017 04:05PM Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology
Sep 13, 2017 04:05PM CytomX to Present at the Cantor Fitzgerald Healthcare Conference
Sep 8, 2017 04:39PM CytomX Announces Upcoming Trials in Progress Poster Presentations at European Society for Medical Oncology Annual Meeting
Aug 10, 2017 04:05PM CytomX to Present at the 2017 Wedbush PacGrow Healthcare Conference
Aug 7, 2017 04:05PM CytomX Announces Second Quarter 2017 Financial Results and Mid-Year Update Webcast Conference Call
Jul 27, 2017 08:00AM CytomX Therapeutics to Announce Second Quarter 2017 Financial Results and Provide Mid-Year Update
Jun 29, 2017 08:06AM CytomX Therapeutics (CTMX) Announces Milestone in Collaboration with AbbVie (ABBV) for CD71-Targeting Probody Drug Conjugate
Jun 29, 2017 08:00AM CytomX Achieves Development Milestone in Strategic Oncology Collaboration with AbbVie for CD71-Targeting Probody Drug Conjugate  
May 25, 2017 08:00AM CytomX to Present at the Jefferies 2017 Global Healthcare Conference
May 17, 2017 08:00AM CytomX Announces Upcoming Poster Presentation at American Society for Clinical Oncology Annual Meeting
May 15, 2017 04:01PM CytomX Announces Management Team Changes
May 5, 2017 08:00AM CytomX Announces First Quarter 2017 Financial Results
Apr 27, 2017 04:05PM CytomX Therapeutics to Announce First Quarter 2017 Financial Results
Mar 30, 2017 08:05AM CytomX Therapeutics (CTMX) Names Marion McCourt to Board of Directors
Mar 30, 2017 08:00AM CytomX Therapeutics Appoints Marion McCourt to Board of Directors
Mar 20, 2017 07:01AM Bristol-Myers Squibb (BMY), CtomX Therapeutics (CTMX) Extend Strategic Collaboration
Mar 20, 2017 06:59AM Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody™ Therapeutics for the Treatment of Cancer and Other Diseases
Mar 19, 2017 07:00PM CytomX Therapeutics Announces Teleconference and Webcast to Provide Corporate Update
Mar 1, 2017 08:00AM CytomX Therapeutics to Announce Full-Year 2016 Financial Results
Oct 14, 2016 08:30AM Cancer Immunotherapy ETF Celebrates One-Year Anniversary
Apr 21, 2016 04:02PM CytomX (CTMX), AbbVie (ABBV) Enter Collaboration to Develop Probody Drug Conjugates Against CD71
Apr 21, 2016 04:01PM AbbVie and CytomX Announce Strategic Collaboration for Probody Drug Conjugates
Apr 21, 2016 04:01PM CytomX and AbbVie Announce Strategic Collaboration for Probody Drug Conjugates
Feb 23, 2016 10:00AM CytomX Therapeutics, Inc. (Nasdaq:CTMX) to Ring The Nasdaq Stock Market Closing Bell
Dec 16, 2015 07:00AM Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
View More Recent Stories View Older Stories